Product Information

BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0787 per EA under NDC 69367028809. Its NADAC has been published 266 times since Jul 21, 2021.

FDA first approved this application on Jun 30, 2017. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL XL 150 MG TABLET

Bupropion Hydrochloride
$0.0787per EA

Strength

150 mg/1

NDC

69367028809

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207224

FDA Approved

6/30/2017

TE Code

AB3

On Market Since

10/1/2017

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 266 times since Jul 21, 2021, and over the history we have for it it has declined 48.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0787 per EA
All-time high$0.1655 (Nov 10, 2021)
All-time low$0.0745 (Nov 20, 2024)
52-week high$0.1015
52-week low$0.0770
Median price$0.1042
Average price$0.1087
Largest weekly change-30.3% (Nov 20, 2024)
Weeks tracked266
Tracking sinceJul 21, 2021

Price History

1W

+1.2%

1M

+1.1%

3M

-0.3%

6M

+0.2%

1Y

-22.5%

3Y

-22.1%

5Y

-49.6%

All

-48.4%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.0787 per EA (NDC 69367028809), effective Aug 19, 2026.

How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 48.4%. It has been tracked across 266 weekly CMS publications since Jul 21, 2021.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?

Since Jul 21, 2021, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.1655 (Nov 10, 2021), with a median of $0.1042 per EA.

Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPROPION HCL XL 150 MG TABLET?

BUPROPION HCL XL 150 MG TABLET (NDC 69367028809) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.